Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001897612-25-000204·AVANOS MEDICAL, INC.
Schedule 13G ownership disclosure
AVANOS MEDICAL, INC.
COMMON STOCK · CUSIP: 05350V106
Event date: 2025-03-31
- Filing-level shares
- 3,757,576
- Percent of class
- 8.2%
- T. Rowe Price Investment Management, Inc.
Shares: 3,757,576 · Class: 8.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-25-000204
- Form type
- SCHEDULE 13G/A
- Filer
- AVANOS MEDICAL, INC.
- CIK
- CIK 1606498
- Filed
- May 14, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership